Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Phosphorylase kinase gamma subunit 1 pseudogene 1 (PHKG1P1) is classified as a pseudogene in the human genome, related to the PHKG1 gene, which encodes the gamma catalytic subunit of phosphorylase kinase—a key enzyme in glycogen metabolism[4][7]. PHKG1P1 does not produce a functional protein, and its principal biological relevance, like other transcribed pseudogenes, may involve RNA-based regulatory roles such as acting as microRNA decoys or participating in competing endogenous RNA networks, modulating the expression of its ancestral gene or related pathways[2][3][5][9]. There is no evidence for direct involvement as a pharmacological or clinical target, and it is not implicated in any specific disease as a direct cause. No drugs are known to target this pseudogene, nor is it used as a biomarker. Its molecular classification is "Other" (pseudogene), and not as a receptor, enzyme, transporter, or transcription factor.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phosphorylase kinase gamma subunit 1 pseudogene 1 (PHKG1P1).